KRAS and neoplasm: Therapeutically, ASOs and siRNA targeting oncogenes like HER2, KRAS, and VEGF, as well as lncRNAs such as HOTAIR and MALAT1, and circRNAs like circPVT1 and circ_0000523, can inhibit cancer-promoting pathways and reduce tumor growth and metastasis.